This is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is.
Post
NEJM.org
nejm.org
did:plc:mgwrki6irihfcatu2v347soc
Remibrutinib in Chronic Spontaneous Urticaria (REMIX-1 and REMIX-2 trials) nej.md/41uQD07
Brief Report: VITT-like Monoclonal Gammopathy of Thrombotic Significance nej.md/4gKmrUs
Subscribe to NEJM for the latest medical research: nej.md/subscribe
2025-03-06T14:06:15.871Z